Clinical Trials at Trinity Health IHA Medical Group Hematology Oncology - Brighton

As of July 2026, 81 paid clinical trials are recruiting at Trinity Health IHA Medical Group Hematology Oncology - Brighton in Brighton, Michigan. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 16, 2026.

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

81 clinical trials at Trinity Health IHA Medical Group Hematology Oncology - Brighton

·Clear filters·↓ Download CSV

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for Core Binding Factor Acute Myeloid Leukemia

Drug: Venetoclax

23 locations incl. Coeur d'Alene

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT06917911·Phase 2·Recruiting

Apply to this trial